Microdosing

GE is in the process of splitting into three companies.  We explore why this is a good thing, and why it needs to be done.  

Jamil Rivers of Chrysalis Initiative talks outcome disparities within breast cancer, and striving to ensure every patient receives the care they deserve.

Donna Walthall of Dana Farber shares her ASCO observations as a fifteen-time attendee, celebrating Dana-Farber’s 75th anniversary

Tim Wolfe of Syapseshare their approach toward Real World Care and Applied Experience

Matthew Schulz, a Medical Science Liaison, shares his observations on this year’s ASCO session.

Chakra Chennubhotlaand Dusty Majumdar of SpIntellx explore the possibilities of empowering researchers and clinicians to unravel the hidden connections in the tumor microenvironment through deep profiling cell-cell communication patterns and spatial relationships.

Anthony Giordano of Sermo shares their latest efforts with the Oncologist community, as well as the impact of their "Run with Peter" charity that is funding cancer research.

Natalie Sacarakis of IQVIA shares how their Cell and Gene Therapy COE can address the unique logistics management and clinical operations challenges around one's CAGT asset and pipeline.

Chelsea Saurer of Kesem - an organization focused on families who have a member suffering from cancer- shares that their live summer camps have returned to in-person summer programming.  

Jen-Tang Lu of Vysioneer shares shares how they are using AI to unlock real-world guideline-based tumor response assessments, and improve clinical trials in that space.